13F-HR filed by NEXTBio Capital Management LP
NEXTBio Capital Management LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 13:51:27 UTC, with 25 holding rows worth $234,373,442.
- Accession
- 0001172661-26-004969
- Filer
- CIK 2038158
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 25 entries on the cover page, a total value of $234,373,442 stated on the cover page (in dollars after the unit check, H1), rows summing to $234,373,442 with VALUE read as dollars as filed, 13F file number 028-26345. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 219,333 | $30,901,826 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 3,727,348 | $25,420,513 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,775,759 | $22,090,442 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 131,758 | $12,545,338 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 620,931 | $11,847,363 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 372,552 | $11,817,349 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 310,225 | $11,537,268 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 426,736 | $11,509,070 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 80,409 | $11,090,813 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 312,496 | $9,771,750 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 684,476 | $9,219,892 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 2,923,937 | $8,508,657 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 906,742 | $7,299,273 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,787,984 | $6,597,661 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 238,362 | $6,278,455 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 107,223 | $6,100,989 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 178,036 | $5,700,713 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 175,403 | $5,612,896 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 372,856 | $5,439,969 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 250,000 | $4,660,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 52,655 | $3,446,796 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 69,549 | $2,669,291 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 100,000 | $1,994,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 111,455 | $1,329,658 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 119,063 | $983,460 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-004969 | this filing | 2026-11-13 |